AA
COCH icon

AQR Arbitrage’s Envoy Medical COCH Stock Holding History

AQR Arbitrage’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-489,251
Closed -$4.94M – 1057
2022
Q4 		$4.94M Buy
489,251
+67,875
+16% +$675K 0.13% 228
2022
Q3 		$4.14M Buy
421,376
+50,298
+14% +$494K 0.09% 306
2022
Q2 		$3.64M Buy
371,078
+87,500
+31% +$857K 0.08% 320
2022
Q1 		$2.77M Hold
283,578
– – 0.07% 309
2021
Q4 		$2.77M Sell
283,578
-24,998
-8% -$244K 0.07% 306
2021
Q3 		$2.99M Buy
308,576
+58,580
+23% +$567K 0.09% 203
2021
Q2 		$2.42M Buy
+249,996
New +$2.43M 0.07% 227

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

AQR Arbitrage's COCH Position: Q1 2023 in Review

AQR Arbitrage sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 489,251 shares — an estimated $4.94M sold.

AQR Arbitrage first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $4.94M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • AQR Arbitrage reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • AQR Arbitrage sold 489,251 Envoy Medical shares in Q1 2023, an estimated $4.94M.
  • AQR Arbitrage first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • AQR Arbitrage's Envoy Medical position peaked at $4.94M in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on AQR Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.